ABSTRACT Alveolar macrophages differ from their percursors in blood, monocytes, by expressing strong activity ofthe tartrate resistant variant ofacid phosphatase (TAcP). A study was carried out to analyse the expression of this enzyme cytochemical marker by alveolar macrophages from bronchoalveolar lavage cells from 34 patients with sarcoidosis and 12 control subjects. Alveolar macrophages from control subjects displayed a strong and homogeneous staining pattern and only 0-1% of cells were negative after staining. Macrophages from patients with sarcoidosis showed reduced TAcP activity and up to 7% of the cells were negative. The percentage of TAcP negative macrophages was correlated with the percentage of lymphocytes and with the ratio of CD4 to CD8 lymphocytes among cells recovered by bronchoalveolar lavage. The reduced TAcP activity in alveolar macophages from patients with sarcoidosis may be due to an increased recruitment of immature precursors from blood.
Introduction
Alveolar macrophages are derived from blood monocytes.' The maturation of alveolar macrophages from their precursors in blood is characterised by the aquisition ofvaried phenotypic and functional properties.2 Among these tartrate resistant acid phosphatase (TAcP) provides an easily detectable enzyme cytochemical marker for alveolar macrophages.3
The alveolitis associated with pulmonary sarcoidosis is characterised by changes in the number, surface phenotype, and activity of both alveolar macrophages and T lymphocytes. 4 Barth, Kreipe, Kiemle-Kallee, Radzun, Parwaresch, Petermann Twelve subjects (mean age 51 (SD 14) years) served as the control group. In the eight with a small peripheral bronchial carcinoma the unaffected lung was lavaged. Four patients were investigated to exclude pulmonary manifestations ofcollagen disease. None ofthe control subjects had abnormal differential counts of the cells recovered by lavage.
Blood monocytes from eight healthy volunteers (mean age 24 (SD 3) years) and from 12 patients with sarcoidosis (mean age 34 (5) years) were separated by density gradient centrifugation followed by glass adherence. Cells were harvested by gentle scraping with a rubber policeman.' Bronchoalveolar lavage of the right middle lobe or lingula was performed.7 Pappenheim staining and immunocytochemical staining of cytospin preparations from lavage cells served to determine the lymphocyte count and the percentage of T lymphocyte subpopulations respectively.' Acid phosphatase activity was visualied by using naphtol-AS-BI-phosphate (Sigma, Munich) as substrate and hexazotised pararosaniline as coupler according to the method of Barka 
Results
Blood monocytes from normal donors and patients with sarcoidosis did not show TAcP activity. By contrast, alveolar macrophages from the control group showed a diffuse and intense TAcP staining pattern (fig la) . Very few alveolar macrophages from control subjects were totally TAcP negative (0-13%, fig 2) . Alveolar macrophages from the patients with sarcoidosis, however, showed reduced TAcP activity on the basis of staining. The staining pattern was characterised by a spotty and inhomogeneous distribution and the proportion of total TAcP negative alveolar macrophages was considerably greater (up to 7%) than in the control group.
In the subgroup analysis ofpatients with sarcoidosis there were more TAcP negative alveolar macrophages in patients with a high percentage of lymphocytes in the lavage fluid, in those with an increased T4:T8 ratio, and in those with stage II radiographic appearances (fig 2) macrophages occurred in patients with a T4:T8 ratio of 5 or more (fig 2) . Regression analysis showed a positive correlation between the number of lavage fluid lymphocytes and the number of TAcP negative alveolar macrophages (r = 0-758, p < 0O005). A less striking but still significant correlation was found between the T4:T8 ratio and the number of TAcP negative alveolar macrophages in patients with sarcoidosis (r = 0-671, p < 0 005).
Discussion
Several lines of evidence indicate that the alveolitis associated with pulmonary sarcoidosis leads to an increased recruitment of monocytes into the lung. Alveolar macrophages in sarcoidosis differ from normal resident macrophages by having a more "immature" surface phenotype, resembling that of blood monocytes. '9 The evidence that alveolar macrophages in sarcoidosis, unlike other macrophage populations, share with blood monocytes the capacity to release a type IV collagenase supports the idea that monocytes actively migrate from the blood to the lung in this disease.'°Moreover, more alveolar macrophages in sarcoidosis retain the ability to proliferate, thus indicating a lower stage of maturation."
Our finding of reduced TAcP expression in alveolar macrophages from patients with sarcoidosis ( fig 1) accords well with the view that the alveolar macrophages in the alveoli in this disease are immature. Blood monocytes from control subjects and from patients with sarcoidosis showed no TAcP activity, whereas alveolar macrophages from control subjects displayed a strong and homogeneous expression of this cytochemical marker. In addition to the reduced TAcP activity observed in almost all alveolar macrophages in the patients with sarcoidosis, there was an increased number of completely TAcP negative alveolar macrophages. When numbers of TAcP negative macrophages were related to indices that presumably mirror disease activity, such as the percentage of lymphocytes among lavage cells and the CD4:CD8 ratio, significantly more negative macrophages were found in patients with more than 30% of lymphocytes and a CD4:CD8 ratio of 5 or more.
Reduction or absence of TAcP activity was observed in some alveolar macrophages with an apparently mature morphology (fig 1) . As macrophages are known to secrete lysosomal enzymes actively in response to an inflammatory challenge,'2 active secretion of these enzymes is an additional mechanism that might account for the reduced TAcP activity in patients with sarcoidosis. The TAcP content of bronchoalveolar lavage fluid must be analysed to test this hypothesis. Further studies are also necessary to evaluate the prognostic relevance of TAcP staining in patients with sarcoidosis, as this may represent an easily detectable marker of disease activity. 
